APA
AUTL

American Portfolios Advisors’s Autolus Therapeutics AUTL Stock Holding History

American Portfolios Advisors’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$36.2K Hold
16,925
– – ﹤0.01% 1892
2022
Q2 		$47.9K Hold
16,925
– – ﹤0.01% 1784
2022
Q1 		$70.6K Buy
16,925
+200
+1% +$841 ﹤0.01% 1715
2021
Q4 		$86.8K Buy
16,725
+3,000
+22% +$18K ﹤0.01% 1580
2021
Q3 		$89.9K Buy
13,725
+675
+5% +$4.26K ﹤0.01% 1505
2021
Q2 		$86.7K Buy
13,050
+2,450
+23% +$15.2K ﹤0.01% 1477
2021
Q1 		$60.7K Buy
10,600
+5,850
+123% +$43.3K ﹤0.01% 1533
2020
Q4 		$42.5K Buy
+4,750
New +$50.6K ﹤0.01% 1480

Other funds holding AUTL

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

American Portfolios Advisors's AUTL Position: Q3 2022 in Review

American Portfolios Advisors held its Autolus Therapeutics (AUTL) position steady in Q3 2022 at 16,925 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

American Portfolios Advisors first reported a position in AUTL in Q4 2020 and has held it in 8 quarters since. The position peaked at $89.9K in Q3 2021. 66 funds tracked by Wall St. Rank hold AUTL as of Q3 2022.

  • American Portfolios Advisors held 16,925 shares of Autolus Therapeutics worth $36.2K as of Q3 2022.
  • American Portfolios Advisors left its Autolus Therapeutics share count unchanged in Q3 2022.
  • Autolus Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1892 holding.
  • American Portfolios Advisors first reported a position in Autolus Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • American Portfolios Advisors's Autolus Therapeutics position peaked at $89.9K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.